Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Apr;33(4):E1-5.
doi: 10.1002/clc.20615.

Statin therapy in patients with diastolic heart failure

Faramarz Tehrani  1 , Ryan Morrissey, Anita Phan, Christopher Chien, Ernst R Schwarz
Affiliations

Statin therapy in patients with diastolic heart failure

Faramarz Tehrani et al. Clin Cardiol. 2010 Apr.

Abstract

Background: There is controversy regarding the potential effects of statin therapy on mortality in patients with heart failure. The present study analyzed the possible effects of statin therapy on morbidity and mortality in patients with diastolic heart failure over long-term follow-up.

Hypothesis: To evaluate potential effect of statin therapy on hospitalization rate and mortality in patients with diastolic heart failure.

Methods: Patients with preserved left ventricular ejection fraction (> or =50%), hospitalized for clinical symptoms of heart failure were evaluated. Patients on statin therapy started at or prior to their first heart failure admission represented group 1 and patients without statin therapy represented group 2. The effects of statins on hospitalization rates and mortality were assessed during a 5 year follow-up.

Results: A total of 270 patients (group 1 n = 81; group 2 n = 189) were followed over 5 years. Patients on statins demonstrated improved survival compared to patients without statin therapy (hazard ratio [HR] = 0.65, 95% confidence interval [CI]: 0.45-0.95, P = .029). The survival benefit was maintained after adjusting for differences in baseline characteristics, comorbidities, and other medications. There was no significant difference in the mean cardiovascular hospitalization rate (3.0 +/- 3.2 vs 3.8 +/- 4.7, P = .23) and in overall hospitalization rate (7.1 +/- 6.3 vs 7.8 +/- 7.7, P = .52) between groups 1 and 2, respectively.

Conclusion: Statin therapy appears to be associated with improved survival in patients with diastolic heart failure.

PubMed Disclaimer

References

    1. Yamada T, Node K, Mine T, et al. Long‐term effect of atorvastatin on neurohumoral activation and cardiac function in patients with chronic heart failure: a prospective randomized controlled study. Am Heart J 2007; 153: 1055e1–8. - PubMed
    1. Khush KK, Waters DD, Bittner V, et al. Effect of high‐dose atorvastatin on hospitalizations for heart failure: subgroup analysis of the Treating to New Targets (TNT) study. Circulation 2007; 115: 576–583. - PubMed
    1. Domanski M, Coady S, Fleg J, Tian X, Sachdev V. Effect of statin therapy on survival in patients with nonischemic dilated cardiomyopathy (from the β‐Blocker Evaluation of Survival Trail [BEST]). Am J Cardiol 2007; 99: 1448–1450. - PubMed
    1. Kjekshus J, Apetrei E, Barrios V, et al. Rosuvastatin in older patients with systolic heart failure. N Engl J Med 2007; 357: 2248–2261. - PubMed
    1. Fukuta H, Sane DC, Brucks S, Little WC. Statin therapy may be associated with lower mortality in patients with diastolic heart failure: a preliminary report. Circulation 2005; 112: 357–363. - PubMed

Substances